Literature DB >> 8740009

DNA-based rhesus typing: simultaneous determination of RHC and RHD status using the polymerase chain reaction.

M Poulter1, T J Kemp, B Carritt.   

Abstract

We describe a PCR-based method of performing RHD and C/c typing in a single reaction. The method is based on an earlier observation of a polymorphism in intron 2 of both genes which, in addition to detecting the RHD deletion responsible for most known D-negative phenotypes, is also associated with C/c serological type. Using this assay, we typed 105 unrelated individuals from at least four different population groups and compared the results to those obtained using conventional serological testing of red cells. An absolute correlation, with no exceptions, was seen. We also showed that the method has potential in the antenatal determination of RH type, as it was possible to type fetal trophoblasts recovered from the endocervical canal at 9 weeks pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740009     DOI: 10.1111/j.1423-0410.1996.tb01316.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D-- phenotype.

Authors:  T J Kemp; M Poulter; B Carritt
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

2.  Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies.

Authors:  Vincenzo Dario Mandato; Federica Torricelli; Valentina Mastrofilippo; Gino Ciarlini; Debora Pirillo; Enrico Farnetti; Loretta Fornaciari; Bruno Casali; Maria Carolina Gelli; Martino Abrate; Lorenzo Aguzzoli; Giovanni Battista La Sala; Davide Nicoli
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

3.  RHD positive haplotypes in D negative Europeans.

Authors:  F F Wagner; A Frohmajer; W A Flegel
Journal:  BMC Genet       Date:  2001-07-16       Impact factor: 2.797

4.  Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran.

Authors:  Reyhaneh Sarihi; Arezoo Oodi; Raziyeh Dadkhah Tehrani; Seyedeh Farzaneh Jalali; Fahimeh Mardani; Azita Azarkeivan; Samira Gudarzi; Naser Amirizadeh
Journal:  Mol Genet Genomic Med       Date:  2021-05-08       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.